Back to Journals » International Journal of Nanomedicine » Volume 13

Silica–gentamicin nanohybrids: combating antibiotic resistance, bacterial biofilms, and in vivo toxicity

Authors Mosselhy DA, He W, Hynönen U, Meng Y, Mohammadi P, Palva A, Feng Q, Hannula SP, Nordström K, Linder MB

Received 3 December 2018

Accepted for publication 3 December 2018

Published 13 December 2018 Volume 2018:13 Pages 8577—8578

DOI https://doi.org/10.2147/IJN.S196872


Mosselhy DA, He W, Hynönen U, et al. Int J Nanomedicine. 2018;13:7939–7957.

 
On page 7945, Figure 1 parts were labeled incorrectly.
 
Read the original article

Silica–gentamicin nanohybrids: combating antibiotic resistance, bacterial biofilms, and in vivo toxicity

Mosselhy DA, He W, Hynönen U, et al. Int J Nanomedicine. 2018;13:7939–7957.

On page 7945, Figure 1 parts were labeled incorrectly. The correct figure is as follows:

Figure 1 SEM images of the materials.
Notes: (A, C) Smooth spherical pristine SiO2 NPs and (B, D) granular rough aggregated network of SiO2-G nanohybrids at the magnifications of 10,000× (A, B) and 20,000× (C, D). (E) The zeta potential of the pristine SiO2 NPs and SiO2-G nanohybrids in deionized water. The error bars represent the standard errors of the means.
Abbreviations: SEM, scanning electron microscope; SiO2 NPs, silica nanoparticles; SiO2-G, silica–gentamicin.

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]